Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Masaryk University
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 25 January 2025
First Online: 28 February 2025
Declarations
:
: The participant has consented to the submission of the case report to the journal.
: TH- Novartis (speakers bureau, consultancy), Angelini Pharma (consultancy), DZ- Novartis (speakers bureau, consultancy, member of advisory board), Angelini Pharma (speakers bureau, consultancy), JM- Novartis (research support), BMS (research support).
